Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes... [including commentary by Raymond Plodkowski].

BACKGROUND: It is estimated that 29.1 million people or 9.3% of the US population have diabetes, which contributes to considerable medical and financial burden. Type 2 diabetes mellitus is characterized by insulin resistance and insulin secretion impairment leading to hyperglycemia. The presence of...

Full description

Bibliographic Details

Published in:	American Health & Drug Benefits Vol. 10; no. 4; pp. 178 - 189
Main Authors:	Lingjet Tran, Kelvin, Young In Park, Pandya, Shalin, Muliyil, Navin John, Jensen, Brandon David, Huynh, Kovin, Quang T. Nguyen
Format:	commentary research tables/charts Journal Article
Published:	Amplity Health Jun2017
Online Access:	View this record in EBSCOhost